Risedronate induces rapid and sustained reductions in vertebral fracture risk in postmenopausal women with established osteoporosis

被引：0
作者：
Eastell, R
Reid, D
Watts, N
Roux, C
Genant, H
Adami, S
Hangartner, T
Miller, P
Sorensen, O
Hooper, M
Ethgen, D
Valent, D
机构：
来源：
OSTEOPOROSIS INTERNATIONAL | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OC26
引用
收藏
页码：S26 / S27
页数：2
相关论文
共 50 条
[41]   Risedronate increases bone mineral density and reduces the vertebral fracture incidence in postmenopausal women [J].
Reginster, JY .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2001, 19 (02) :121-122
[42]   Risedronate (Actonel((R))): Significant and rapid Fracture Risk Reduction in Osteoporosis [J].
不详 .
JOURNAL FUR MINERALSTOFFWECHSEL, 2008, 15 (02) :109-109
[43]   Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis - A randomized controlled trial [J].
Harris, ST ;
Watts, NB ;
Genant, HK ;
McKeever, CD ;
Hangartner, T ;
Keller, M ;
Chesnut, CH ;
Brown, J ;
Eriksen, EF ;
Hoseyni, MS ;
Axelrod, DW ;
Miller, PD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (14) :1344-1352
[44]   The effect of risedronate on hip fracture risk in elderly women with osteoporosis. [J].
Bensen, W ;
Eastell, R ;
Reginster, J ;
McClung, M .
JOURNAL OF RHEUMATOLOGY, 2001, 28 :24-24
[45]   Osteoporosis Therapy in Postmenopausal Women With High Risk of Fracture [J].
Cappola, Anne R. ;
Shoback, Dolores M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (07) :715-716
[46]   Determinants of imminent fracture risk in postmenopausal women with osteoporosis [J].
Barron, R. L. ;
Oster, G. ;
Grauer, A. ;
Crittenden, D. B. ;
Weycker, D. .
OSTEOPOROSIS INTERNATIONAL, 2020, 31 (11) :2103-2111
[47]   Determinants of imminent fracture risk in postmenopausal women with osteoporosis [J].
R. L. Barron ;
G. Oster ;
A. Grauer ;
D. B. Crittenden ;
D. Weycker .
Osteoporosis International, 2020, 31 :2103-2111
[48]   Risedronate at both 2.5 mg and 5.0 mg daily doses reduces the risk of hip fracture in women with established osteoporosis [J].
McClung, Michael R. ;
Purple, Christopher R. ;
Zhou, Xiaojie ;
Watts, Nelson .
OSTEOPOROSIS INTERNATIONAL, 2007, 18 :S215-S215
[49]   Bazedoxifene reduces the risk of fracture in women with postmenopausal osteoporosis [J].
Nature Clinical Practice Rheumatology, 2008, 4 (11) :566-566
[50]   Clinical evaluation of osteoporosis and fracture risk in postmenopausal women [J].
McClung B. .
Clinical Reviews in Bone and Mineral Metabolism, 2006, 4 (1) :15-23
12345